A detailed history of Bank Of America Corp transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Bank Of America Corp holds 115 shares of LEXX stock, worth $247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Previous 96 19.79%
Holding current value
$247
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.58 - $4.09 $49 - $77
19 Added 19.79%
115 $0
Q2 2024

Aug 14, 2024

SELL
$1.99 - $4.0 $280 - $564
-141 Reduced 59.49%
96 $0
Q1 2024

May 15, 2024

BUY
$1.29 - $6.25 $305 - $1,481
237 New
237 $0

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $12.8M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.